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Abstract
Background: Thrombospondin-1 (TSP-1) is involved in many biological processes, including immune and tissue injury
response, but its role in sepsis is unknown. Cell surface expression of TSP-1 on platelets is increased in sepsis and could
activate the anti-inflammatory cytokine transforming growth factor beta (TGFb1) affecting outcome. Because of these
observations we sought to determine the importance of TSP-1 in sepsis.
Methodology/Principal Findings: We performed studies on TSP-1 null and wild type (WT) C57BL/6J mice to determine the
importance of TSP-1 in sepsis. We utilized the cecal ligation puncture (CLP) and intraperitoneal E.coli injection (IP E.coli)
models of peritoneal sepsis. Additionally, bone-marrow-derived macrophages (BMMs) were used to determine phagocytic
activity. TSP-12/2 animals experienced lower mortality than WT mice after CLP. Tissue and peritoneal lavage TGFb1 levels
were unchanged between animals of each genotype. In addition, there is no difference between the levels of major innate
cytokines between the two groups of animals. PLF from WT mice contained a greater bacterial load than TSP-12/2 mice
after CLP. The survival advantage for TSP-12/2 animals persisted when IP E.coli injections were performed. TSP-12/2
BMMs had increased phagocytic capacity compared to WT.
Conclusions: TSP-1 deficiency was protective in two murine models of peritoneal sepsis, independent of TGFb1 activation.
Our studies suggest TSP-1 expression is associated with decreased phagocytosis and possibly bacterial clearance, leading to
increased peritoneal inflammation and mortality in WT mice. These data support the contention that TSP-1 should be more
fully explored in the human condition.
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Introduction
Severe sepsis and septic shock are conditions that affect millions
every year, killing approximately 30% of those afflicted [1]. By
recent projections the incidence and morbidity of sepsis are
increasing 1–3. This clinical syndrome is believed to be triggered
by bacterial products released from a previously localized infection
that leads to a systemic inflammatory reaction and organ
impairment [4]. These triggers drive organ failure and worse
outcomes potentially through dysregulation of the immune
response, activation of platelets and coagulation cascades which
propagates the inflammatory response [5]. Of the various sepsis
syndromes, peritoneal sepsis due to visceral pathology or
spontaneous bacterial translocation has a very high mortality rate
of 60–80% [2,3,6].
TSP-1 is a matrix glycoprotein with diverse roles in numerous
cellular and physiologic processes [7]. The primary source of TSP-
1 is activated platelets, where it comprises 25% of the total protein
content of its alpha-granules [8]. Other tissues and cells including
leukocytes and endothelial cells can also produce this matricellular
protein [8–10]. Platelet surface expression of TSP-1 is increased in
patients with sepsis, and polymorphisms in TSP-1 are associated
with developing sepsis-related organ failure [11,12]. TSP-1
expression is thought to play an important role in multiple
biological processes including thrombosis, wound healing and the
immune response [13–16]. It can influence the regulation of
innate immune functions directly through its effects on phagocytic
cell migration and indirectly through activation of the potent anti-
inflammatory cytokine transforming growth factor beta (TGFb1)
[17,18]. TGFb1 has been shown to be important to the
development of sepsis-related organ failure and the inflammatory
response to infections [19,20].
The immune system’s ability to contain local infections is an
important part of the normal response to infection. In peritoneal
sepsis related to disrupted bowel integrity, local wound healing and
bacterial clearance are important components of this response
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cascade can begin to locally control injury, but controlled
inflammation drives further cellular and cytokine responses leading
to wound healing [21]. Prior studies have demonstrated that
fibroblasts[22–24], collagen production [25], and fibrogenic growth
factors (Connective tissue growth factor, CTGF; TGFb1; Vascular
endothelial growth factor, VEGF) [15,16,26,27] are important in
thisprocess. Additionally, the recruitment of phagocytes is critical to
this local bacterial clearance [28]. When microorganisms cannot be
controlled locally, bacteremia can result [4,5].
A potential role for TSP-1 in the pathogenesis of sepsis has not
been previously shown. Our primary aim was to determine if
survival in murine severe sepsis was affected by TSP-1 status. We
hypothesized that TSP-1 could influence sepsis outcome through
either an effect on local wound healing at the site of surgical injury
after cecal ligation and puncture (CLP) or bacterial clearance.
Here, we demonstrate that mice deficient in TSP-1 have improved
survival and bacterial clearance in murine models of sepsis.
Results
TSP-12/2 mice are protected from CLP-related mortality
and experience lower peritoneal bacterial load despite
equal cecal injury
We induced polymicrobial sepsis in WT and TSP-1 2/2 mice
via cecal-ligation and puncture (CLP) that results in reproducible
inflammatory injury [29]. WT mice had an observed mortality of
95% within 72 hours of CLP, a rate significantly higher than
TSP-12/2 mice (Figure 1A). Sham operation resulted in 100%
seven-day survival regardless of genotype. To characterize the
intra-abdominal response, peritoneal lavage fluid (PLF) was
analyzed for cellular composition, inflammatory cytokines and
bacterial load. TSP-1 2/2 and WT mice developed similar
peritoneal cellular responses after CLP (Table 1), but there was a
significantly higher peritoneal bacteria count observed in WT
mice after CLP (Figure 1B). In addition, WT animals and
TSP-1 2/2 animals had no significant differences in PLF KC
(IL-8), Tumor necrosis factor-a, IL-6 or IL-1b for up to 24 hours
after CLP (n=3 for each background and time point, 6, 12 and
24 hours after CLP). Serum inflammatory cytokines (IL-1b, IL-6,
TNF-alpha, KC and HMGB1) were not significantly different
12 hours after CLP (Table 2). Peritoneal bacterial burden
correlated well with bacterial quantity in cultured splenic
homogenates, suggesting worsened bacteremia in WT mice
(Figure 1C). Based on these findings, we sought to understand
why local control of peritoneal infection was enhanced in
TSP-1 2/2 mice.
TSP-12/2 macrophages have increased phagocytic
capacity and are protected from mortality in a non-
surgical infectious model of peritoneal sepsis
As stated earlier, the number and type of inflammatory cells
(Table 1) and PLF pro-inflammatory cytokines were similar
between WT and TSP-12/2 mice, therefore differences in
phagocytic function could lead to changes in bacterial clearance
and therefore quantity at fixed times after contamination. Using
BMMs in a well-defined phagocytosis assay [30], we observed that
TSP-12/2 macrophages ingested 70% higher amounts of
opsonized SRBCs than WT (Figure 2A–C). This differences in
activity could not be explained by the proportion of cells
expressing phagocytic markers (CD64) on all peritoneal cells
(3.0% TSP2/2 vs. 4.8% WT, p=0.22) or only those co-
expressing macrophage markers (F4/80) (20.7% TSP2/2 vs.
22.8% WT, p=0.71). To determine the relevance of these in vitro
findings, we performed survival studies between the two
backgrounds in a purely infectious model of peritonitis. This
approach minimizes the possibility that mortality is related to
surgical wound healing or variation in fecal contamination of the
peritoneum, while still investigating bacterial contamination of the
peritoneum. We injected 5610
9 CFU/ kg E.coli IP to LD50 for
WT and TSP-12/2 mice [31]. Survival for TSP-12/2 mice was
significantly higher than that observed in WT after E.coli injection
(p=0.028, Figure 2D).
TSP-1 deficient and WT mice exhibit similar wound
healing after CLP
Because TSP-1 is known to be involved in epithelial wound
healing [32] and CLP is a surgical injury that requires healing for
survival, a separate cohort was studied to determine the effect of
TSP-1 status on cecal wound healing. We assayed ceca from CLP
in TSP-12/2 and WT mice for TGFb, CTGF and VEGF. We
did not find a significant difference in CTGF or TGFb protein at
any time point within the first 24 hours after CLP (Figure 3A, C).
VEGF mRNA was statistically different from WT expression after
CLP with the point estimate being higher at the 3 and 12 hour
timepoint, but lower at 6 hours in TSP-12/2 compared to WT
(Figure 3B). No differences in the amount of peritoneal lavage fluid
TGFb1 protein were observed between WT and TSP-12/2
animals.
To confirm the significance of our fibrogenic growth factor
assays, collagen I protein and mRNA were measured. Neither of
these parameters was affected 12 or 24 hours after injury by the
presence of functional TSP-1 (Figure 3D and 3E). Sham-treated
cecal tissues had no detectable expression of collagen protein or
message (data not shown). Finally, in a fibroblast scratch assay
TSP-12/2 fibroblasts showed normal mobility relative to WT
fibroblasts, suggesting one critical aspect of wound closure is not
different between the genotypes (Figure 3F).
Discussion
The data presented in this report highlights the importance of
TSP-1 in macrophage phagocytosis, bacterial clearance, and
outcome in two models of murine sepsis. Taken together, this
suggests that TSP-1 expression could impact outcome through a
negative effect on innate immune function in patients with severe
sepsis. Given that murine TSP-1 deficiency is associated with
increased circulating and infiltrating leukocytes [33], our obser-
vations suggest that TSP-1 could serve to both reduce leukocyte
infiltration and its phagocytic function.
Previous studies have suggested that TSP-1’s role in inflamma-
tion is due to TGFb1 activation. TSP-1 has been shown to activate
latent TGFb1 in vitro, and TSP-12/2 mice recapitulate many of
the same phenotypes that TGFb12/2 mice display [33]. Thus, it
is believed that TSP-1 can activate TGFb1 in vivo [34]. More
recent data suggests that interaction of the LAP-binding integrins
avb6 and avb8 with latent TGFb1 may play a more central role in
activation [35]. Additionally, LAP may independently utilize TSP-
1 interactions to induce a biologic response [17], suggesting that
other roles for TSP-1 could be more important than activation of
TGFb1. In peritoneal sepsis, it appears that non-TSP related
mechanisms activate TGFb1, as levels of the active protein
localized to the area of injury (ceca) or surrounding environment
(peritoneal lavage fluid) were unchanged in TSP-12/2 mice
compared to WT mice after CLP. Additionally, there appeared to
be no differences in peritoneal lavage fluid pro-inflammatory
cytokines after CLP, suggesting, in part, that TSP-1’s role in the
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following induction of surgical peritonitis. WT and TSP-12/2 mice were subjected to either CLP or sham surgery as described in Materials and
Methods on Day 0. A. Mice were monitored for a course of 7 days for survival (p,0.001 by Kaplan-Meier, n=20 WT CLP, n=20 TSP-12/2 CLP). All
mice receiving sham surgeries survived until study end (7 days) (n=5 WT sham, n=6 TSP-12/2sham). B. Mice underwent CLP surgery at hour 0 and
were euthanized at various time points after surgery. Sterile peritoneal lavage was performed and colony-forming unit counts were performed on the
lavage fluid from mice 3, 6, 12, and 24 hours after the CLP procedure. Data represents 3 mice per time point, and error bars are +/2SEM (*p,0.05, for
6, 12 and 24 hours after CLP, ANOVA). C. Spleens were harvested under sterile conditions from WT and TSP-12/2mice 3 hours post-CLP. Organs
were then crushed under sterile conditions. Data represents colony-forming unit counts from total organ protein of 3 mice per genotype and error
bars are +/2SEM (*p=0.04).
doi:10.1371/journal.pone.0019654.g001
Table 1. Peritoneal lavage fluid cell counts after CLP.
% of total
Parameter Total Cells Neutrophils Macrophages Lymphocytes
WT 3 hrs 6.0610
561.1610
5 9560.6 3.360.3 1.760.7
TSP-12/2 3 hrs 8.3610
563.3610
5 9660.3 3.060.1 1.360.3
WT 6 hrs 3.9610
664.0610
5 9060.6 8.360.9 1.760.3
TSP-12/2 6 hrs 3.3610
66 9.6610
5 8960.7 8.760.3 2.060.6
WT 12 hrs 1.9610
766.6610
6 6460.3 3361.0 3.360.9
TSP-12/2 12 hrs 1.1610
764.9610
6 6561.2 3261.0 3.060.6
Data represent mean 6 SEM. n=3 for WT at 3,6,12 hours, n=3 for TSP-12/2 at 3,6,12 hours.
doi:10.1371/journal.pone.0019654.t001
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TGFb1.
In tumor microenvironment studies, TSP-1 can act as a
monocyte chemoattractant [17,36,37]. Yet, we observed no
difference in the number or type of leukocytes recruited after
CLP between TSP-12/2 and WT mice. Previous reports have
implicated TSP-1 expression as essential to phagocytosis of
apoptotic fibroblasts and neutrophils, but little is known about
TSP-1 role in response to bacterial challenge [38,39]. Our data
suggests that TSP-1 deficiency confers increased viability after
septic insult by upregulating innate immune responsiveness
leading to more rapid clearance of peritoneal bacteria without
effecting cytokine production. We show that murine macrophages
lacking TSP-1 display an increased capacity for FccR-mediated
phagocytosis. This phagocytic difference appears relevant as it is
supported by increased survival in TSP-12/2 mice compared to
WT mice after isolated bacterial challenge. The mechanism
Table 2. Serum pro-inflammatory cytokine analysis.
TSP deficiency WT p-value
VEGF 105.3 (67.7–117.6) 193.3 (90.2–245.9) 0.18
IL-1beta 342.1 (108.5–557.8) 394.0 (378.1–795.3) 0.16
IL-6 603.3 (230.2–685.5) 1,577.1 (596.7–1788.7) 0.46
KC 2,347.6 (1707.4–3800.1) 3,029.9 (2324.9–3734.9) 1.00
TNF-alpha 289.9 (223.9–319.2) 323.6 (263.5–712.2) 0.21
HMGB1 17.5 (11.5–26.3) 62.5 (4.9–230.0) 0.61
Data represent median (25
th–75
th percentile). n=9 for WT or TSP deficient
animals at 12 hours after CLP; all pg/ml except HMGB1 in ng/ml.
doi:10.1371/journal.pone.0019654.t002
Figure 2. Mice containing functional TSP-1 protein have decreased phagocytic capacity as compared to mice lacking functional
TSP-1, and show increased survival in a non-surgical model of sepsis. BMMs were co-incubated with IgG-opsonized, labeled sheep red
blood cells and phagocytic index was determined via blinded counting of ingested red blood cells per 100 macrophages. Phase contrast images of
BMMs overlayed with images of SRBCs ingested are shown for WT mice (A) and TSP-12/2 mice (B). C. The quantification of phagocytic capacity is
indicated by phagocytic index. Images and Data represent n=3 for WT animals and n=3 for TSP-12/2 animals, and error bars are +/– SEM (*p,0.01
by student’s t test). D. WT and TSP-12/2 mice were subjected to either E.coli or PBS injection as described in Materials and Methods on Day 0. Mice
were monitored for a course of 7 days for survival (p,0.001 by Kaplan-Meier, n=40 WT CLP, n=40 TSP-12/2 e.coli injection). All mice receiving sham
surgeries lived the course of 7 days (n=5 WT PBS, n=5 TSP-12/2 PBS).
doi:10.1371/journal.pone.0019654.g002
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actively pursued in our laboratory, but at present is unknown.
These findings are made more relevant by the observation that
TSP-1 expression can be observed in critically ill patients with
severe sepsis [11]. While it is possible this is only secondary to
platelet activation, there may be some biologic importance to its
elevation during sepsis given the demonstrated effect on
phagocytic function in the current report. The susceptibility of
critically ill patients to nosocomial infections is well described [40],
yet its causes are not completely delineated. Because critically ill
and septic patients have been demonstrated to have reduced
phagocytic function [40,41], it is possible that TSP-1 mediates at
least part of this response.
There are several limitations to our studies. First we have only
presented several select important measures of wound healing in
our analysis and our number of animals could lead us to falsely
concluding no significant difference exists in these markers. While
this is remediable, we believe the concordance of the observations
and the early mortality in these animals make it unlikely that either
lavage inflammation or wound healing factors are likely to play an
important role in larger studies. Secondly, we have not defined the
precise mechanisms whereby the absence of TSP-1 leads to
increased bacterial clearance. While cell counts and differentials
are similar between TSP-1 2/2 and WT animals undergoing
CLP, it is possible that the activation or phagocytic state is altered
and this remains undefined. Thirdly, we do not have data to
Figure 3. TSP-1 deficient and WT mice exhibit similar amounts of wound healing markers after CLP. CLP surgery was performed on WT
and TSP-12/2 mice, and cecums were harvested 3, 6, and 12 hours afterwards and immediately processed for protein and RNA assessment [CTGF (A)
and VEGF (B) and collagen I (E)]. [For all panels, WT (black bars) and TSP-12/2 (white bars); error bars represent 6SEM] A. Cecal CTGF transcript is
shown for each timepoint after surgery. Data represents n=6 for WT and TSP-12/2 at each timepoint. B. Cecal VEGF transcript is shown for each
timepoint after surgery. Data represents n=5 for 3 hours, n=6 for 6 hours and n=3 for 12 hours. C. Cecal protein lysates were assessed via ELISA for
active TGFb1. Data represents active TGFb1i n5 0mg total protein/sample (n=6). D. Cecums were harvested at 12 and 24 hours after CLP and
collagen measured via Sircoll Assay. Data represents n=3 for all timepoints. E. Cecal collagen I transcript is shown for each timepoint after surgery.
Data represents n=6 for background and timepoint. F. WT and TSP-1 2/2 fibroblasts were compared in their ability to close a mechanical scratch in
vitro by scratch closure assay. The mechanical defect was photographed hourly for 48 hours, and unclosed scratch area (‘‘wound’’ size) was
determined using Photoshop. Data points represent the ‘‘wound’’ size at each time point for each background [n=4 for WT (black squares) and n=5
for TSP-12/2 (white squares)].
doi:10.1371/journal.pone.0019654.g003
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genetic background. This could lead to higher intraperitoneal
bacterial count between the two backgrounds with equal fecal
spillage. While this is possible, the presence of similar survival
advantage when using a non-surgical method for peritoneal sepsis
(IP live E. coli injection) in TSP-1 2/2 animals where fecal
spillage does not play a role and standard inoculums are injected
makes this unlikely. Finally, our observations in knockout animals
were not supplemented with a transgenic animal model and as a
result we do not know if true ‘‘over-expression’’ would yield similar
results. We hope to explore these further in more dedicated
human studies in the future to add to the relevance of the murine
observations.
In summary, we demonstrate that the presence of TSP-1 in
murine sepsis is associated with increased mortality and reduced
bacterial clearance. This observation is not explained by TSP-1’s
well-characterized role in wound healing, but rather by an
associated negative regulation of innate immune cell phagocytic
capacity. These observations deserve further investigation in
human peritoneal and non-peritoneal sepsis.
Materials and Methods
Ethics Statement
All animal experiments were designed in accordance with the
expectations of and approved in advance by The Ohio State
University Institutional Animal Care and Use Committee. All
procedures for experiments and monitoring for suffering were
generated and applied after Veterinarian approval through this
committee in accordance with international standards. This
protocol was approved under application number 2009A0124.
Mouse cecal-ligation and puncture (CLP) and peritoneal
inoculation studies
Male mice aged 30–60 days on the C57BL/6J background were
used for these experiments. TSP-12/2 mice were a kind gift of
Dr. Jack Lawler (Harvard Medical School). These mice were
generated by placing a neo insertion in exons 2–3 that disrupts
ability to make functional TSP-1 protein, as previously published
[36]. All mice were maintained in pathogen-free conditions and
provided with food and water. For CLP experiments, mice (n=20
per group) were anesthetized using 2% isoflurane, and a midline
abdominal incision was made exposing the peritoneal cavity. One
cm of the cecum was ligated using braided silk suture (Deknatal,
Research Triangle Park, N.C.), and a sterile 22 gauge needle (B–
D, Franklin Lakes, N.J.) was used to make 4 puncture holes in the
ligated cecum. The original incision was closed using Dexon II
absorbable sutures (Syneture, Norwalk, CT) and VetBond Tissue
Adhesive (3M, St. Paul, MN). Sham surgeries were performed
using the same abdominal incision and closure methods, but ceca
were not ligated or punctured. The peritoneal injection of E.coli to
induce sepsis was performed as previously described.[30] Briefly,
mice (n=40 per group) were injected with 5610
9 colony-forming
units (CFU)/kg E.coli strain BL21DE3/kg weight resuspended in
sterile PBS [31]. Control mice were injected with sterile PBS only.
Survival was monitored for both techniques over the course of 7
days. Blinded personnel monitored mice for signs of distress. When
mice appeared to be in extreme distress they were euthanized.
Euthanized mice are included in all observed survival data.
Organ collection and protein/RNA isolation
In experiments separate from the survival studies, mice (n$3
animals per group) were euthanized at specific times after surgical
procedure. We planned for at least three animals per group, but to
ensure at least three animals per group survived to the appropriate
endpoint, six animals underwent treatment. As a result of death
before the specified timepoint the actual measured n was between
three and six. Cecal tissue just distal to the ligation point from
CLP-treated mice was compared to tissue 1 cm above the cecal tip
from sham treated mice. Cecal tissues were either flash-frozen or
flushed with sterile PBS and placed in 10% formalin for
immunohistochemistry. Organs were crushed using a tissue
homogenizer (Kontes Glass Co., Vineland, N.J.). Protein was
extracted using Cell Signaling Lysis Buffer (Cell Signaling
Technology, Danvers, MA). RNA was extracted using the Trizol
method (Invitrogen, Carlsbad, CA).
Quantitative Real-Time PCR. mRNA was converted to
cDNA using SuperScript III reagents (Invitrogen). Quantitative
real-time PCR for VEGF, type I collagen, CTGF, TSP-1 and
GAPDH. Endogenous control was performed using SYBR Green I
reagents (Eurogentech NA, San Diego, CA) on a 7900HT Fast
Real-Time PCR System (Applied Biosystems, Foster City, CA). All
primers were designed using Primer Express software (Applied
Biosystems). Primer sequences: mouse VEGF: 59-TTACTGC-
TGTACCTCCACC-39 (forward), 59-ACAGGACGGCTTGAA-
GATG-39 (reverse); mouse type I collagen: 59-ATGGATTCC-
CGTTCGAGTACG-39 (forward), 59-TCAGCTGGATAGCGA-
CATCG-39(reverse); mouse CTGF:59-AAAGTGCATCCGGAC-
ACCTAA-39 (forward), 59-TGCAGCCAGAAAGCTCAAACT-39
(reverse); mouse GAPDH: 59-GCACAGTCAAGGCCGAGAAT-
39 (forward); 59-GCCTTCTCCATGGTGGTGAA-39 (reverse).
Protein Assays
Homogenized ceca (n$3 animals per group) were assayed for
active TGFb1 via ELISA (R&D Systems, Minneapolis, MN). For
measurement of collagen, mouse ceca were homogenized in
1.5 ml of 0.5 M acetic acid and rocked overnight at 4uC. Samples
were centrifuged for 10 minutes at 2,000 rpm, and the resulting
supernatant was assessed for collagen according to the manufac-
turer’s instructions (Biocolor Ltd., Belfast, Northern Ireland).
Cytokine assays were performed using the BioRad Bioplex murine
specific inflammatory cytokine panel (BioRad, Hercules, CA) for
all cytokines except HMGB1. HMGB1 assays were performed on
a dedicated ELISA kit and performed on mouse serum to
manufacturer specifications (IBL International GMBH, Hamburg,
Germany).
Lavage Collection and Analysis
Immediately following sacrifice, the peritoneal cavity of mice
(n$3 animals per group) was washed using 5 ml sterile PBS and
10 ml syringe fitted with catheter tube and needle. To determine
amount of bacterial load from the peritoneal cavity, total lavage
fluid was plated on chocolate agar and incubated overnight at
37uC and quantified as colony forming units (CFU). Total fluid
was then spun in a clinical centrifuge at 1700 RPM and fluid
portion was frozen at 220uC. To determine active TGFb1,
ELISA assays were performed (R&D Systems, Minneapolis, MN).
Analysis was done using an ELx808 Microplate Reader (Bio-Tek
Instruments, Winooski, VT). A standard curve R
2 value of $0.98
was considered acceptable for sample analysis. Cellular portion
was resuspended in PBS. Total cell amount was counted using
trypan blue and a hemacytometer. Cell differentials were
determined using a Cytospin apparatus and Diffquick staining.
Fibroblast Scratch Assays
2 cm of the distal ends of mouse ceca were obtained from WT
and TSP-12/2 mice for fibroblast isolation. Colons were washed
2 times in PBS, incubated in 0.04% NaOH for 30 min, then
TSP-1 and Sepsis Mortality
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then minced and placed in DMEM/10% FBS (Invitrogen) and
incubated for 2 weeks at 37C with washing and media changes
every 2 days to obtain primary fibroblasts. Fibroblasts were plated
in 12-well plates and allowed to reach 80% confluency for scratch
assays. Wells were scratched with a 10 mL pipet tip and washed 2
times with PBS, then filled with DMEM/10% FBS. Cells were
kept at 37uC and 5% CO2 with a LiveCell system (Neue
Biosciences, Camp Hill, PA). Fibroblast mobility was observed
using a Nikon Eclipse TE2000U microscope (Nikon Instruments,
Melville, NY) and MetaMorph software (Molecular Devices,
Downington, PA) hourly over a course of 48 hours. Scratch
closure was measured by measuring pixels of unfilled area and
fibroblast area from images using Photoshop software (Adobe, San
Jose, CA).
Phagocytosis Assays
The derivation of bone marrow-derived macrophages (BMMs)
was performed as previously described.[42] Briefly, macrophages
were derived from the bone marrow of WT and TSP-12/2 mice
using a 7-day course of MCSF in RPMI/5% FBS (Mediatech,
Manassas, VA). To measure phagocytosis, we used a previously
described protocol [30]. Briefly, cells were dissociated using sterile
swabs and resuspended at a density of 1610
6 cells/mL in sterile
PBS/0.5% FBS (Mediatech) and co-incubated with IgG-opsonized
and PKH26 Red Fluorescent-labeled sheep red blood cells
(SRBCs) for 1 hour at 37uC (Sigma-Aldrich, St. Louis, MO;
Colorado Serum Company, Denver, CO). Cells were then washed
and non-ingested SRBCs were lysed with hypotonic water.
Samples were fixed in 1% formaldehyde and placed on
microscope slides for blinded counting using an Olympus BX41
microscope and MicroSuite Special Edition software (Olympus
America Inc, Center Valley, PA). Phase contrast pictures of
BMMs were overlayed with fluorescent pictures showing ingested
SRBCs using Adobe Photoshop software.
Flow cytometry
Alveolar macrophages were collected from mouse lung BAL
(n$5 animals per group) and washed once in PBS. Cells were
counted and equal numbers of cells were resuspended in flow
cytometry buffer (1% BSA, 0.1% Sodium Azide in PBS). To block
Fcc receptors I/II, cells were incubated with mouse CD16/32 IgG
(BD Biosciences, San Diego, CA) on ice for 15 minutes then
incubated with anti-CD64 conjugated to PE (BD Biosciences) on
ice for 30 minutes. Cells that were immunostained with F4/80-
APC conjugated antibody (AbD Serotec, Raleigh, NC), were
subjected to a prior incubation with mouse IgG (Jackson
ImmnuoResearch, West Grove, PA) to block Fcc receptors. After
immunostaining, cells were washed in flow cytometry buffer and
fixed in 1% paraformaldehyde solution prior to flow cytometry
analysis (LSRII; BD Biosciences). Data was analyzed using FCS3
Express software from De Novo Software (Los Angeles, CA). The
proportion of CD64 and F4/80 positive cells are presented as the
percent of all gated cells and are expressed as the mean 6 SEM.
Statistical Analysis
Survival studies were carried out to seven days post intervention
and characterized by the methods of Kaplan-Meier. Differences in
survival across genotypes (WT vs. TSP-12/2) was compared
using the log-rank test. Differences in colony forming units (CFU)
across genotypes and time were tested using linear regression.
Specifically we stabilized the variance of CFU across genotypes
and normalized the distribution by using a cubed-root transfor-
mation and then regressed the dependent variable on time and
genotype including their interaction. If this interaction was not
significant, then it was dropped from the regression model. A two-
sample t-test was used to compare the cubed-root of CFU between
genotypes at 3 hours post CLP and to compare the phagocyctic
index between genotypes. Delta cycle time from RT-PCR was
used to compare expression levels CTGF mRNA, VEGF mRNA,
and collagen 1 mRNA over genotype and time. Specifically
ANOVA was used to determine if there was an overall difference
in the delta cycle times. If this difference was significant, then a
post hoc test comparing delta cycle times across genotypes for each
time point after CLP was run. The p-values from the post hoc test
were adjusted using the Holm’s procedure to conserve the overall
type I error at 0.05. This same procedure was used to compare
active TGFb1 and compare total collagen 1 across genotype and
time. Random-effects linear regression was used to test if wound
closure was different over genotype and time. Specifically we log
transformed the wound size percentage and tested if the slopes
(halving times) of each genotype was significantly different from
zero (not decreasing with time) and test if the slopes were
significantly different across genotypes. We also included an
indicator variable that took into account early wound healing and
late wound healing and tested these slope for each period. The cut
point between early and late wound healing was determined post
hoc after observing the graphed wound size percentage for each
genotype. Finally, cytokine data in Table 2 were found to be non-
normally distributed by the skewness and kurtosis test. As a result
the Kruskal-Wallis test was used for analysis and data are now all
represented as medians and IQR. All analyses were run on Stata
11.1, Stata Corporation, College Station, TX.
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